Insider Transactions in Q3 2025 at Ocular Therapeutix, Inc (OCUL)
Insider Transaction List (Q3 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 09
2025
|
Pravin Dugel Director |
BUY
Bona fide gift
|
Indirect |
49,754
+50.0%
|
-
|
|
Sep 09
2025
|
Pravin Dugel Director |
SELL
Bona fide gift
|
Direct |
49,754
-1.54%
|
-
|
|
Sep 02
2025
|
Donald Notman Officer |
SELL
Open market or private sale
|
Direct |
1,066
-0.34%
|
$12,792
$12.43 P/Share
|
|
Aug 25
2025
|
Pravin Dugel Director |
SELL
Open market or private sale
|
Direct |
21,494
-0.66%
|
$257,928
$12.04 P/Share
|
|
Aug 25
2025
|
Jeffrey S. Heier Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
3,063
-1.16%
|
$36,756
$12.04 P/Share
|
|
Aug 25
2025
|
Sanjay Nayak Chief Strategy Officer |
SELL
Open market or private sale
|
Direct |
1,885
-0.67%
|
$22,620
$12.04 P/Share
|
|
Aug 25
2025
|
Peter Kaiser Chief Development Officer |
SELL
Open market or private sale
|
Direct |
3,011
-1.45%
|
$36,132
$12.04 P/Share
|
|
Aug 12
2025
|
Nadia Waheed Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
40,363
+14.04%
|
-
|
|
Aug 11
2025
|
Pravin Dugel Director |
BUY
Bona fide gift
|
Indirect |
250,361
+50.0%
|
-
|